Delivery Order SPE2DB22D1017-SPE2DB25FYREM
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order on August 1, 2025, by the Defense Logistics Agency for ZORYVE 0.3% Foam in a 60-gram unit, with a ceiling value of $1,291.47. The contract is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and was awarded on a competitive basis with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- On July 30, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,202.16 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in 60-gram units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 31, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for ZORYVE 0.3% Foam 60GM pharmaceutical product, valued at $4,330.47. This firm fixed price delivery order, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram units, with a contract ceiling value of $1,242.98. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4,...
- The Defense Logistics Agency awarded a delivery order valued at $1,898.80 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a topical pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on September 2, 2025, with a completion date of September 3, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,288.33 delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ZORYVE is a topical dermatological treatment used primarily for inflammatory skin conditions, and this delivery order reflects...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,092.43 to supply ZORYVE 0.3% Foam in 60-gram units. This contract represents a child delivery order under a larger indefinite delivery contract vehicle, utilizing firm fixed-price pricing with no set-aside designation. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $23,646.57 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with a completion date of September 12, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,246.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for ZORYVE 0.3% Foam in a 60-gram format, with performance completion targeted for April 22, 2025. This non-set-aside contract was awarded competitively and is being performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ZORYVE 0.3% Foam 60GM, a topical dermatological medication. This firm fixed price delivery order, valued at $1,158.98, represents a non-set-aside competitive award with an ultimate completion date of August 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYREMDelivery Order
This delivery order, awarded September 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides ZORYVE 0.3% Foam in 60-gram quantities with a ceiling value of $1,179.18. The contract represents a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procedures with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, has demonstrated consistent capability to fulfill federal medical procurement requirements across multiple therapeutic domains through its extensive portfolio of delivery orders with DLA and the Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/18/25 |